Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
ABCA4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Macular Dystrophy Panel Invitae United States | 66 | 36 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Retinitis pigmentosa 19, 601718; RP19 (Retinitis pigmentosa) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Stargardt Disease (STGD) and Macular Dystrophies Panel PreventionGenetics United States | 35 | 28 |
|
PreventionGenetics United States | 91 | 82 |
|
Autosomal Recessive Retinitis Pigmentosa (RP) Panel PreventionGenetics United States | 62 | 60 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC Netherlands | 4 | 1 |
|
ABCA4 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 4 | 1 |
|
ABCA4 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 4 | 1 |
|
Baylor Genetics United States | 4 | 1 |
|
ABCA4 Deletion/Duplication Analysis (Prenatal Diagnosis) Baylor Genetics United States | 4 | 1 |
|
ABCA4 Deletion/Duplication Analysis Baylor Genetics United States | 4 | 1 |
|
ABCA4 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 4 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Stargardt disease, Fundus Flavimaculatus or Retinal Dystrophy, Early-Onset Severe via the ABCA4 Gene PreventionGenetics United States | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.